Amplification of functional myeloid-derived suppressor cells during stem cell mobilization induced by granulocyte colony-stimulation-factor

Abstract

The effects of granulocyte colony-stimulation-factor (G-CSF) on stem cell mobilization and its impact on the amplification of myeloid-derived suppressor cells (MDSCs) of donor mice were examined. A mouse model of stem cell mobilization was established by consecutive subcutaneous injection of 100 μg/kg G-CSF for 5 days. The blood from the donor mice was routinely examined during mobilization. Stem cells and MDSCs were analyzed by flow cytometry. The immunosuppressive molecules derived from MDSCs in serum and spleen, including hydrogen dioxide (H₂O₂) and nitric oxide (NO), and the activity of nitric oxide synthase (NOS) were determined during the mobilization. Apoptosis of T lymphocytes was assessed by using Annexin-V/PI. During stem cell mobilization, the number of lymphocytes and white blood cells in the peripheral blood was increased, and peaked on the 4th day. The number of stem cells in G-CSF-treated mice was significantly greater than that in controls (P<0.01). The expansions of MSDCs were also observed after G-CSF mobilization, with a more notable rate of growth in the peripheral blood than in the spleen. The activity of NOS and the production of NO were increased in the donor mice, and the serum H₂O₂ levels were approximately 4-fold greater than the controls. Consequently, apoptosis of T lymphocytes was increased and showed a positive correlation with the elevated percentage of MDSCs. It was concluded that G-CSF could provide sufficient peripheral blood stem cells for transplantation. Exogenous administration of G-CSF caused the accumulation of MDSCs in the peripheral blood and the spleen, which could lead to apoptosis of T lymphocytes and may offer a new strategy for the prevention and treatment of graft versus host disease.

Keywords

myeloid-derived suppressor cells / granulocyte colony-stimulation-factor / stem cell mobilization / transplantation / immunosuppressive molecules

References

[1] PaczesnyS. Discovery and validation of graft-versus-host disease biomarkers. Blood, 2013, 121(4): 585-594

[2] GratwohlA, BaldomeroH, HorisbergerB, et al.. Current trends in hematopoietic stem cell transplantation in Europe. Blood, 2002, 100(7): 2374-2386

[3] GoniO, AlcaideP, FresnoM. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly₆G (Gr1 (+)) CD11b(+) immature myeloid suppressor cells. Int Immunol, 2002, 14(10): 1125-1134

[4] ArpinatiM, GreenCL, HeimfeldS, et al.. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 2000, 95(8): 2484-2490

[5] CauleyLS, MillerEE, YenM, et al.. Superantigeninduced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J Immunol, 2000, 165(11): 6056-6066

[6] EzernitchiAV, VakninI, Cohen-DanielL, et al.. TCR zeta downregulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol, 2006, 177(7): 4763-4772

[7] WangD, YuY, HaarbergK, et al.. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant, 2013, 19(5): 692-702

[8] HighfillSL, RodriguezPC, ZhouQ, et al.. Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft-versus-host disease (GVHD) via an arginase-1 dependent mechanism that is upregulated by IL-13. Blood, 2010, 116(25): 5738-5747

[9] CashenAF, LazarusHM, DevineSM. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?. Bone Marrow Transplant, 2007, 39(10): 577-588

[10] LemoliRM. New strategies for stem cell mobilization. Mediterr J Hematol Infect Dis, 2012, 4(1): e2012066

[11] RossettiM, GregoriS, RoncaroloMG, et al.. Granulocytecolony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells. Eur J Immunol, 2010, 40(11): 3097-3106

[12] ZengD, Dejbakhsh-JonesS, StroberS, et al.. Granulocyte colony stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transportation. Blood, 1997, 90(1): 453-463

[13] LechnerMG, LiebertzDJ, EpsteinAL, et al.. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol, 2010, 185(4): 2273-2284

[14] KusmartsevS, GabrilovichDI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother, 2008, 55(3): 237-245

[15] DugastAS, HaudebourgT, CoulonF, et al.. Myeloidderived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol, 2008, 180(12): 7898-7906